Regulation of complexin 1 and complexin 2 in the developing human prefrontal cortex

Synapse

Volumn 62, Issue 4, 2008, Pages 273-282

  Salimi, Kayvon ^a   Glantz, Leisa A ^a,b   Hamer, Robert M ^a,b,c   German, Thomas T ^a   Gilmore, John H ^a,b   Jarskog, L Fredrik ^d,e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Adolescence; Brain; Cortical; Development; Postmortem; Protein; Synaptic

Indexed keywords

BRAIN PROTEIN; COMPLEXIN 1; COMPLEXIN 2; NEUROTRANSMITTER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN DEVELOPMENT; BRAIN MATURATION; BRAIN REGION; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROMODULATION; NEUROTRANSMITTER RELEASE; PREFRONTAL CORTEX; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; REGULATORY MECHANISM; SCHOOL CHILD; WESTERN BLOTTING;

EID: 40549136468     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20492     Document Type: Article

References (68)

1. Barr AM, Hofmann CE, Phillips AG, Weinberg J, Honer WG. 2005. Prenatal ethanol exposure in rats decreases levels of complexin proteins in the frontal cortex. Alcohol Clin Exp Res 29: 1915–1920.
2. Berghuis P, Dobszay MB, Sousa KM, Schulte G, Mager PP, Hartig W, Gorcs TJ, Zilberter Y, Ernfors P, Harkany T. 2004. Brain‐derived neurotrophic factor controls functional differentiation and microcircuit formation of selectively isolated fast‐spiking GABAergic interneurons. Eur J Neurosci 20: 1290–1306.
3. Bourgeois JP, Goldman‐Rakic PS, Rakic P. 1994. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex 4: 78–96.
4. Chuang DM, Hough C, Senatorov VV. 2005. Glyceraldehyde‐3‐phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 45: 269–290.
5. Chugani HT, Phelps ME, Mazziotta JC. 1987. Positron emission tomography study of human brain functional development. Ann Neurol 22: 487–497.
6. Cobb SR, Buhl EH, Halasy K, Paulsen O, Somogyi P. 1995. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378: 75–78.
7. Cruz DA, Eggan SM, Lewis DA. 2003. Postnatal development of pre‐ and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J Comp Neurol 465: 385–400.
8. Do T, Kerr B, Kuzhikandathil EV. 2007. Brain‐derived neurotrophic factor regulates the expression of D1 dopamine receptors. J Neurochem 100: 416–428.
9. Eastwood SL, Burnet PW, Harrison PJ. 2000. Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse 36: 167–177.
10. Eastwood SL, Harrison PJ. 2000. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: A study of complexin mRNAs. Mol Psychiatry 5: 425–432.
11. Eastwood SL, Harrison PJ. 2001. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP‐43 and the complexins. Brain Res Bull 55: 569–578.
12. Eastwood SL, Harrison PJ. 2005. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: Further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73: 159–172.
13. Erickson SL, Lewis DA. 2002. Postnatal development of parvalbumin‐ and GABA transporter‐immunoreactive axon terminals in monkey prefrontal cortex. J Comp Neurol 448: 186–202.
14. Feinberg I. 1982. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 17: 319–334.
15. Ferguson RE, Carroll HP, Harris A, Maher ER, Selby PJ, Banks RE. 2005. Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 5: 566–571.
16. Freeman W, Morton AJ. 2004a. Differential messenger RNA expression of complexins in mouse brain. Brain Res Bull 63: 33–44.
17. Freeman W, Morton AJ. 2004b. Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation. Brain Res Bull 63: 45–55.
18. Fuster JM. 2002. Frontal lobe and cognitive development. J Neurocytol 31: 373–385.
19. Gao WJ, Goldman‐Rakic PS. 2003. Selective modulation of excitatory and inhibitory microcircuits by dopamine. Proc Natl Acad Sci USA 100: 2836–2841.
20. Gao WJ, Krimer LS, Goldman‐Rakic PS. 2001. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Natl Acad Sci USA 98: 295–300.
21. Gibson HE, Reim K, Brose N, Morton AJ, Jones S. 2005. A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse. Eur J Neurosci 22: 1701–1712.
22. Giraudo CG, Eng WS, Melia TJ, Rothman JE. 2006. A clamping mechanism involved in SNARE‐dependent exocytosis. Science 313: 676–680.
23. Glantz LA, Gilmore JH, Hamer RM, Lieberman JA, Jarskog LF. 2007. Synaptophysin and PSD‐95 in the human prefrontal cortex from mid‐gestation into early adulthood. Neuroscience 149: 582–591.
24. Glynn D, Bortnick RA, Morton AJ. 2003. Complexin II is essential for normal neurological function in mice. Hum Mol Genet 12: 2431–2448.
25. Glynn D, Drew CJ, Reim K, Brose N, Morton AJ. 2005. Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits. Hum Mol Genet 14: 2369–2385.
26. Glynn D, Sizemore RJ, Morton AJ. 2007. Early motor development is abnormal in complexin 1 knockout mice. Neurobiol Dis 25: 483–495.
27. Harrison PJ, Eastwood SL. 1998. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352: 1669–1673.
28. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC. 1995. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200: 151–154.
29. Huang ZJ, Kirkwood A, Pizzorusso T, Porciatti V, Morales B, Bear MF, Maffei L, Tonegawa S. 1999. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98: 739–755.
30. Huttenlocher PR. 1979. Synaptic density in human frontal cortex—Developmental changes and effects of aging. Brain Res 163: 195–205.
31. Huttenlocher PR, Dabholkar AS. 1997. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387: 167–178.
32. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. 2004. Apoptotic proteins in the temporal cortex in schizophrenia: High Bax/Bcl‐2 ratio without caspase‐3 activation. Am J Psychiatry 161: 109–115.
33. Kinnunen AK, Koenig JI, Bilbe G. 2003. Repeated variable prenatal stress alters pre‐ and postsynaptic gene expression in the rat frontal pole. J Neurochem 86: 736–748.
34. Koenig JI, Elmer GI, Shepard PD, Lee PR, Mayo C, Joy B, Hercher E, Brady DL. 2005. Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: Potential relevance to schizophrenia. Behav Brain Res 156: 251–261.
35. Kroner S, Krimer LS, Lewis DA, Barrionuevo G. 2006. Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type‐specific modulation of interneurons. Cereb Cortex 17: 1020–1032.
36. Lambe EK, Krimer LS, Goldman‐Rakic PS. 2000. Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J Neurosci 20: 8780–8787.
37. Lazarini F, Deslys JP, Dormont D. 1991. Regulation of the glial fibrillary acidic protein, beta actin and prion protein mRNAs during brain development in mouse. Brain Res Mol Brain Res 10: 343–346.
38. Lewis DA. 1997. Development of the prefrontal cortex during adolescence: Insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16: 385–398.
39. Lewis DA, Cruz D, Eggan S, Erickson S. 2004. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia. Ann NY Acad Sci 1021: 64–76.
40. Lewis DA, Lieberman JA. 2000. Catching up on schizophrenia: Natural history and neurobiology. Neuron 28: 325–334.
41. Lustig RH, Hua P, Wilson MC, Federoff HJ. 1993. Ontogeny, sex dimorphism, and neonatal sex hormone determination of synapse‐associated messenger RNAs in rat brain. Brain Res Mol Brain Res 20: 101–110.
42. Markram H, Toledo‐Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C. 2004. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5: 793–807.
43. Marz KE, Hanson PI. 2002. Sealed with a twist: Complexin and the synaptic SNARE complex. Trends Neurosci 25: 381–383.
44. McMahon HT, Missler M, Li C, Sudhof TC. 1995. Complexins: Cytosolic proteins that regulate SNAP receptor function. Cell 83: 111–119.
45. Ohba S, Ikeda T, Ikegaya Y, Nishiyama N, Matsuki N, Yamada MK. 2005. BDNF locally potentiates GABAergic presynaptic machineries: Target‐selective circuit inhibition. Cereb Cortex 15: 291–298.
46. Ono S, Baux G, Sekiguchi M, Fossier P, Morel NF, Nihonmatsu I, Hirata K, Awaji T, Takahashi S, Takahashi M. 1998. Regulatory roles of complexins in neurotransmitter release from mature presynaptic nerve terminals. Eur J Neurosci 10: 2143–2152.
47. Perrot‐Sinal TS, Davis AM, McCarthy MM. 2001. Developmental sex differences in glutamic acid decarboxylase (GAD(65)) and the housekeeping gene. GAPDH. Brain Res 922: 201–208.
48. Polleux F, Lauder JM. 2004. Toward a developmental neurobiology of autism. Ment Retard Dev Disabil Res Rev 10: 303–317.
49. Pouille F, Scanziani M. 2001. Enforcement of temporal fidelity in pyramidal cells by somatic feed‐forward inhibition. Science 293: 1159–1163.
50. Reim K, Mansour M, Varoqueaux F, McMahon HT, Sudhof TC, Brose N, Rosenmund C. 2001. Complexins regulate a late step in Ca2+‐dependent neurotransmitter release. Cell 104: 71–81.
51. Romanczyk TB, Weickert CS, Webster MJ, Herman MM, Akil M, Kleinman JE. 2002. Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan. Eur J Neurosci 15: 269–280.
52. Rosenberg DR, Lewis DA. 1995. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol 358: 383–400.
53. Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ, Falkai P, Phillips AG, Honer WG. 2005. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 62: 263–272.
54. Sawada K, Young CE, Barr AM, Longworth K, Takahashi S, Arango V, Mann JJ, Dwork AJ, Falkai P, Phillips AG, Honer WG. 2002. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 7: 484–492.
55. Schaub JR, Lu X, Doneske B, Shin YK, McNew JA. 2006. Hemifusion arrest by complexin is relieved by Ca2 +‐synaptotagmin I. Nat Struct Mol Biol 13: 748–750.
56. Spencer KM, Nestor PG, Perlmutter R, Niznikiewicz MA, Klump MC, Frumin M, Shenton ME, McCarley RW. 2004. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci USA 101: 17288–17293.
57. Takahashi S, Ujihara H, Huang GZ, Yagyu KI, Sanbo M, Kaba H, Yagi T. 1999. Reduced hippocampal LTP in mice lacking a presynaptic protein: Complexin II. Eur J Neurosci 11: 2359–2366.
58. Takahashi S, Yamamoto H, Matsuda Z, Ogawa M, Yagyu K, Taniguchi T, Miyata T, Kaba H, Higuchi T, Okutani F. 1995. Identification of two highly homologous presynaptic proteins distinctly localized at the dendritic and somatic synapses. FEBS Lett 368: 455–460.
59. Tang J, Maximov A, Shin OH, Dai H, Rizo J, Sudhof TC. 2006. A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. Cell 126: 1175–1187.
60. Tokumaru H, Umayahara K, Pellegrini LL, Ishizuka T, Saisu H, Betz H, Augustine GJ, Abe T. 2001. SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis. Cell 104: 421–432.
61. Webster MJ, Weickert CS, Herman MM, Kleinman JE. 2002. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res 139: 139–150.
62. Weickert CS, Webster MJ, Gondipalli P, Rothmond D, Fatula RJ, Herman MM, Kleinman JE, Akil M. 2006. Postnatal alterations in dopaminergic markers in the human prefrontal cortex. Neuroscience 144: 1109–1119.
63. Weisinger G, Gavish M, Mazurika C, Zinder O. 1999. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: Tissue‐ and treatment‐specificity. Biochim Biophys Acta 1446: 225–232.
64. Woo NH, Lu B. 2006. Regulation of cortical interneurons by neurotrophins: From development to cognitive disorders. Neuroscientist 12: 43–56.
65. Woo TU, Pucak ML, Kye CH, Matus CV, Lewis DA. 1997. Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience 80: 1149–1158.
66. Yamada M, Saisu H, Ishizuka T, Takahashi H, Abe T. 1999. Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: Localization at the distinct central nervous system regions and synaptic types. Neuroscience 93: 7–18.
67. Zaitsev AV, Gonzalez‐Burgos G, Povysheva NV, Kroner S, Lewis DA, Krimer LS. 2005. Localization of calcium‐binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex 15: 1178–1186.
68. Zehr JL, Todd BJ, Schulz KM, McCarthy MM, Sisk CL. 2006. Dendritic pruning of the medial amygdala during pubertal development of the male Syrian hamster. J Neurobiol 66: 578–590.